Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.
Publication
, Journal Article
Montefiori, DC
Published in: Cell Rep Med
March 15, 2022
A study by Kitchin, Richardson et al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Cell Rep Med
DOI
EISSN
2666-3791
Publication Date
March 15, 2022
Volume
3
Issue
3
Start / End Page
100579
Location
United States
Related Subject Headings
- Viral Vaccines
- SARS-CoV-2
- Humans
- COVID-19
- Antibodies, Viral
- Ad26COVS1
- 32 Biomedical and clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Montefiori, D. C. (2022). Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med, 3(3), 100579. https://doi.org/10.1016/j.xcrm.2022.100579
Montefiori, David C. “Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.” Cell Rep Med 3, no. 3 (March 15, 2022): 100579. https://doi.org/10.1016/j.xcrm.2022.100579.
Montefiori DC. Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med. 2022 Mar 15;3(3):100579.
Montefiori, David C. “Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.” Cell Rep Med, vol. 3, no. 3, Mar. 2022, p. 100579. Pubmed, doi:10.1016/j.xcrm.2022.100579.
Montefiori DC. Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection. Cell Rep Med. 2022 Mar 15;3(3):100579.
Published In
Cell Rep Med
DOI
EISSN
2666-3791
Publication Date
March 15, 2022
Volume
3
Issue
3
Start / End Page
100579
Location
United States
Related Subject Headings
- Viral Vaccines
- SARS-CoV-2
- Humans
- COVID-19
- Antibodies, Viral
- Ad26COVS1
- 32 Biomedical and clinical sciences